In a study recently published in Nature Biotechnology, a team of medical researchers from around the world announced new open source software that “could make it easier to create personalised cancer treatment plans.”
The software assesses “the proportion of cancerous cells in a tumour sample” and can help clinicians “judge the accuracy of computer predictions and establish benchmarks” across tumor samples. Maxime Tarabichi, one of the lead authors of the study, said that the software “provides a foundation which will hopefully become a much-needed, unbiased, gold-standard benchmarking tool for assessing models that aim to characterise a tumour’s genetic diversity.”
Source: opensource.com
